AptarGroup(NYSE:ATR) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Jul 28, 2016. Company reported revenue of $620.00M. Analysts estimated a revenue of $621.52M. Earnings per share were $0.91. Analysts had estimated an EPS of $0.90.
AptarGroup (ATR) made into the market gainers list on Thursdays trading session with the shares advancing 0.21% or 0.16 points. Due to strong positive momentum, the stock ended at $76.78, which is also near the day’s high of $77.49. The stock began the session at $76.74 and the volume stood at 1,72,619 shares. The 52-week high of the shares is $81.5 and the 52 week low is $63.62. The company has a current market capitalization of $4,849 M and it has 6,31,55,792 shares in outstanding.
Several Insider Transactions has been reported to the SEC. On Jun 2, 2016, Stephen J Hagge (President and CEO) sold 25,000 shares at $76.84 per share price.Also, On Mar 21, 2016, Robert Kuhn (EVP & CFO) sold 5,000 shares at $76.43 per share price.On Mar 21, 2016, Peter Pfeiffer (director) sold 143,000 shares at $76.97 per share price, according to the Form-4 filing with the securities and exchange commission.
AptarGroup Inc. is a solution provider of a range of packaging delivery solutions for the beauty personal care home care prescription drug consumer health care injectables food and beverage markets. The Company has manufacturing facilities located throughout the world including North America Europe Asia and South America. It offers various dispensing and sealing solutions. Its primary products are dispensing pumps closures aerosol valves and elastomer primary packaging components. It also manufactures and sells elastomer primary packaging components which include stoppers for infusion antibiotic lyophilization and diagnostic vials. Its elastomer components also include pre-filled syringe components such as plungers needle shields tip caps and cartridges as well as dropper bulbs and disposable syringe plungers. The Company’s segments include Beauty + Home Pharma and Food + Beverage.